1. Home
  2. ESTA vs IRON Comparison

ESTA vs IRON Comparison

Compare ESTA & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Establishment Labs Holdings Inc.

ESTA

Establishment Labs Holdings Inc.

HOLD

Current Price

$70.15

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$61.69

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESTA
IRON
Founded
2004
2017
Country
Costa Rica
United States
Employees
N/A
155
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ESTA
IRON
Price
$70.15
$61.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$82.63
$101.67
AVG Volume (30 Days)
504.5K
950.6K
Earning Date
05-14-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
42.67
N/A
EPS
N/A
N/A
Revenue
$61,208,000.00
N/A
Revenue This Year
$27.95
N/A
Revenue Next Year
$26.20
$101.57
P/E Ratio
N/A
N/A
Revenue Growth
76.49
N/A
52 Week Low
$26.56
$30.82
52 Week High
$83.31
$99.50

Technical Indicators

Market Signals
Indicator
ESTA
IRON
Relative Strength Index (RSI) 43.95 37.56
Support Level $63.74 $57.45
Resistance Level $71.95 $64.00
Average True Range (ATR) 4.81 3.78
MACD -0.86 -0.15
Stochastic Oscillator 29.16 40.11

Price Performance

Historical Comparison
ESTA
IRON

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: